glp-1 medications orlando fl TrimRX Hard to party on a
Description
Diabetes Care 33(2):428433 Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M et al (2015) Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J)
PMID 15090972
doi: 10.2337/diabetes.50.3.609

Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S (2020) Nonalcoholic steatohepatitis: a review

Globally, obesity rates are accelerating significantly, compelling the healthcare professionals to prescribe these drugs mainly for their certified efficacy in facilitating weight loss, particularly in diabetic patients

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (Wegovy)